Videos de Experimentos Relacionados
Prueba de palito de inmersión para programas de control del tracoma.
Hugh R Taylor1, Heathcote R Wright
1Centre for Eye Research Australia, University of Melbourne, WHO Collaborating Centre for the Prevention of Blindness, East Melbourne, Victoria 3002, Australia. h.taylor@unimelb.edu.au
Lancet (London, England)
|May 16, 2006
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.
PLoS neglected tropical diseases·2026
Same author
Diabetic retinopathy screening in Australian general practice: persistently low uptake despite national guidelines and equity initiatives.
Journal of diabetes and metabolic disorders·2025
Same author
Inherited retinal disease in global Indigenous populations: A scoping review.
Survey of ophthalmology·2025
Same author
Effective refractive error coverage in adults: a systematic review and meta-analysis of updated estimates from population-based surveys in 76 countries modelling the path towards the 2030 global target.
The Lancet. Global health·2025
Same author
National Eye Institute's (NEI) coordination efforts and current opportunities for sustainability, adaptation, and climate resilience in global eye health - ARVO 2023 session commentary.
Eye (London, England)·2023
Same author
Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countries.
The Lancet. Global health·2022
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026